Form 4 for EW Edwards Lifesciences
Accepted 2023-09-06 00:00:00 ET · period of report 2023-09-06 · accession 0001225208-23-008737 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-09-06 | 2023-09-06 | EW | Chopra Daveen | CVP, TMTT | M - OptEx | $59.26 | +8,500 | 32.5K | +35% | +$503.7K |
| D | 2023-09-06 | 2023-09-06 | EW | Chopra Daveen | CVP, TMTT | S - Sale+OE | $76.07 | -8,500 | 23.9K | -26% | -$646.6K |
| D | 2023-09-06 | 2023-09-06 | EW | Chopra Daveen | CVP, TMTT | M - OptEx | $0.00 | -8,500 | 26.0K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-06 | M | A | 8,500 | $59.26 | 32,450 | D | — | — | |
| 2 | Common | Common Stock | 2023-09-06 | S | D | 8,500 | $76.07 | 23,950 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $75.83 to $76.42. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Derivative | Employee Stock Option (Right to Acquire) | 2023-09-06 | M | D | 8,500 | $0.00 | 26,000 | D | $59.26 · 2020-05-08 to 2026-05-07 | 8,500 Common Stock |